Please login to the form below

Not currently logged in
Email:
Password:

Genesis Biopharma names Hans Bishop as chair

Former chief operating officer of Dendreon joins specialist in cancer immunotherapies

Former chief operating officer of Dendreon Hans Bishop has been appointed executive chair of the board at Genesis Biopharma.

The US biotech specialises in cancer immunotherapies and Bishop first joined Genesis as a director in the beginning of 2012.

He will take over from Anthony Cataldo who will remain at the firm as a director.

“To support our business plan we have been expanding our leadership with talented, experienced professionals,” said Cataldo.

“The addition of Hans as our executive chair further enhances this dynamic team as he is a proven leader with an impressive track record of enhancing operational and financial results.”

Prior to his role at Dendreon, Bishop served as president of Bayer's speciality medicine business division from 2006 until 2009, leading units in oncology, neurology, ophthalmology and haematology.

From 2004 to 2006 he held the position of senior VP, global commercial operations for Chiron Corporation, now part of Novartis.

Commenting on his appointment, Bishop said: “It is a privilege to serve as executive chair of Genesis Biopharma at this important point in the company's evolution.  I look forward to building a strong leadership team & working with my colleagues on the board to steer the company to success.”

30th March 2012

Share

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Streaming Well

Streaming Well is a healthcare-focused, award-winning video production company which operates in the US and Europe. We create engaging visual...

Latest intelligence

July 2020: diversity and inclusion in clinical trials round-up
COVID-19 has continued to bring diversity and health inequality to the forefront of people’s attention. Our latest round-up covers the July news around these issues, and brings you the latest...
Medical Device Clinical Trials 2020
In July 2020, we attended and exhibited at the Medical Device Clinical Trials 2020 Virtual Experience. We really enjoyed the day and it was great to hear from like-minded people,...
Article: What's next? How behavioural science can support pharma's future
...

Infographics